Abstract:Background The genetic architectures of colorectal cancer are distinct across different populations. To date, the majority of polygenic risk scores (PRSs) are derived from European (EUR) populations, which limits their accurate extrapolation to other populations. Here, we aimed to generate a PRS by incorporating East Asian (EAS) and EUR ancestry groups and validate its utility for colorectal cancer risk assessment among different populations. Methods A large-scale colorectal cancer genome-wide association study (GWAS), harboring 35,145 cases and 288,934 controls from EAS and EUR populations, was used for the EAS-EUR GWAS meta-analysis and the construction of candidate EAS-EUR PRSs via different approaches. The performance of each PRS was then validated in external GWAS datasets of EAS (727 cases and 1452 controls) and EUR (1289 cases and 1284 controls) ancestries, respectively. The optimal PRS was further tested using the UK Biobank longitudinal cohort of 355,543 individuals and ultimately applied to stratify individual risk attached by healthy lifestyle. Results In the meta-analysis across EAS and EUR populations, we identified 48 independent variants beyond genome-wide significance ( P < 5 × 10 −8 ) at previously reported loci. Among 26 candidate EAS-EUR PRSs, the PRS-CSx approach-derived PRS (defined as PRS CSx ) that harbored genome-wide variants achieved the optimal discriminatory ability in both validation datasets, as well as better performance in the EAS population compared to the PRS derived from known variants. Using the UK Biobank cohort, we further validated a significant dose-response effect of PRS CSx on incident colorectal cancer, in which the risk was 2.11- and 3.88-fold higher in individuals with intermediate and high PRS CSx than in the low score subgroup ( P trend = 8.15 × 10 −53 ). Notably, the detrimental effect of being at a high genetic risk could be largely attenuated by adherence to a favorable lifestyle, with a 0.53% reduction in 5-year absolute risk. Conclusions In summary, we systemically constructed an EAS-EUR PRS to effectively stratify colorectal cancer risk, which highlighted its clinical implication among diverse ancestries. Importantly, these findings also supported that a healthy lifestyle could reduce the genetic impact on incident colorectal cancer.

Construction and optimization of a polygenic risk model for venous thromboembolism in the Chinese population

Evaluating the predictive value of genetic risk score in colorectal cancer among Chinese Han population

Cardiovascular Disease Risk Prediction Models in Chinese Population- A Systematic Review and Meta-Analysis

Construction of Risk Assessment Model for Venous Thromboembolism after Colorectal Cancer Surgery: A Chinese Single-Center Study

Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations

Assessing the Risk for Development of Deep Vein Thrombosis among Chinese Patients Using the 2010 Caprini Risk Assessment Model: A Prospective Multicenter Study.

Multi-ancestry polygenic risk scores for venous thromboembolism

Development and Validation of a Polygenic Risk Score for Stroke in the Chinese Population

Association Analysis and Polygenic Risk Score Evaluation of 38 Gwas-Identified Loci in A Chinese Population with Parkinson'S Disease

Common genetic risk factors for venous thrombosis in the Chinese population

Identification of potential genetic Loci and polygenic risk model for Budd-Chiari syndrome in Chinese population

Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: Evidence from the China Kadoorie Biobank

Whole Exome Sequencing Identifies Genetic Variants in Chinese Han Pregnant Women with Venous Thromboembolism-a Case Control Study

Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese

Venous thromboembolism risk assessment of surgical patients in Southwest China using real-world data: establishment and evaluation of an improved venous thromboembolism risk model

Predicting the occurrence of venous thromboembolism: construction and verification of risk warning model

Risk prediction of developing venous thrombosis in combined oral contraceptive users

An Improved Genome-Wide Polygenic Score Model for Predicting the Risk of Type 2 Diabetes

A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population

Development of a Polygenic Risk Score to Improve Detection of Peripheral Artery Disease

Genetic Insights through Chinese VTE Pedigree Interpretation Using the ACMG Method: Unraveling Potencial Genetic Risk Factors